cp wire

CP Wire Articles

Teva and Regeneron's Fasinumab Meets Primary and Secondary Endpoints in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip

Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced on 8/16/18 positive topline results from a Phase 3, randomized, double-blind,... read more

Thu, 08/16/18 - 09:58 am
Dose Escalation Cohort to be Initiated in Adaptimmune's MAGE-A4 SPEAR T-Cell Basket Study

Adaptimmune Therapeutics plc (Nasdaq:ADAP) announced on 8/14/18 a favorable review of safety data from the second dose cohort of patients who received one billion transduced SPEAR T‑cells... read more

Wed, 08/15/18 - 09:50 am
CEL-SCI Gets Independent Recommendation to Continue PH III Head and Neck Cancer Trial

CEL-SCI Corporation (NYSE American: CVM) announced on 8/15/18 that the Independent Data Monitoring Committee (IDMC) for the Company's pivotal Phase 3 head and neck cancer study of its... read more

Wed, 08/15/18 - 09:27 am
Onspira Therapeutics' OSP-101 Receives Orphan Drug Designation for Bronchiolitis Obliterans
  • No currently approved drugs for Bronchiolitis Obliterans
  • OSP-101 is the first and only inhaled interleukin-1 receptor antagonist
  • Nearly 80 percent of lung transplant... read more
Tue, 08/14/18 - 10:31 am
Ironshore Pharmaceuticals Books $143 Million with Private Placement

Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc., announced on 8/14/18 that it has entered into agreements with purchasers... read more

Tue, 08/14/18 - 10:13 am

Pages